| Cettire Limited (CTT) ORDINARY FULLY PAID |
Consumer Discretionary |
$84 |
H1 FY26 Appendix 4D and Financial Report
|
26 Feb 2026 9:47AM |
$0.450 |
$0.220 |
fallen by
51.11%
|
|
CTT - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax of $1,053,619 for the period ending December 31, 2025
- Sales revenue decreased by 3% to $382.8 million due to softer U.S. demand
- Average order value increased by 17% to $961
- Advertising and marketing expenses reduced
- Cash balance of $61.4 million with zero financial debt
- Directors believe the company can continue as a going concern
- No significant changes in the state of affairs during the financial period
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$380 |
1H26 Financial Results and Equity Raising Webcast Details
|
26 Feb 2026 9:46AM |
$1.715 |
$0.565 |
fallen by
67.06%
|
|
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$22 |
H1 FY26 Results Presentation
|
26 Feb 2026 9:46AM |
$0.038 |
$0.024 |
fallen by
36.84%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 6% to $2.18 million in H1 FY26.
- Significant orders for HIV Self-Test kits with government support.
- Cash balance of $3.51 million with no debt.
- Pascal OEM business orders surged, primarily for FebriDx.
- Operational expansion to support increased production capacity.
- Focus on expanding international market reach, particularly in Europe and Asia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Active Limited (WAA) ORDINARY FULLY PAID |
Financials |
$151 |
Record invest. port. outperformance, 2026 Half Year Results
|
26 Feb 2026 9:46AM |
$1.040 |
$1.020 |
fallen by
1.92%
|
|
WAA - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Active Limited (ASX: WAA) investment portfolio significantly outperformed for the 12 and six-month periods to 31 December 2025.
- The investment portfolio increased by 41.4% and 31.4% respectively, attributable to stock selections and dynamic portfolio construction.
- The company declared an increased fully franked interim dividend of 3.2 cents per share and a special fully franked dividend of 1.0 cents per share.
- WAM Active's investment strategy and team expertise are credited for delivering excellent investment portfolio performance.
- The dividends declared equate to an annualised fully franked interim dividend yield of 6.2% and a grossed-up dividend yield of 8.9%.
- Since inception, WAM Active has paid 104.7 cents per share in fully franked dividends.
- The company raised $70.7 million through an oversubscribed Entitlement Offer in February 2026, increasing assets by 84%.
- The increased capital base is expected to enhance market liquidity, broker coverage, and access to market opportunities.
- WAM Active has shifted portfolio positioning towards precious and base metals, anticipating outperformance due to macroeconomic trends.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thrive Tribe Technologies Limited (1TT) ORDINARY FULLY PAID |
Information Technology |
$2 |
Completion of Capital Raise
|
26 Feb 2026 9:46AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Bioxyne Limited (BXN) ORDINARY FULLY PAID |
Consumer Staple |
$136 |
Half Yearly Report and Accounts
|
26 Feb 2026 9:46AM |
$0.052 |
$0.060 |
risen by
15.38%
|
|
BXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Record sales revenue of $31,309,739 for the half year ended 31 December 2025.
- Profit before tax from continuing operations was $7,341,585.
- Bioxyne Limited reported a 149% revenue increase compared to the prior corresponding period.
- Net profit after tax attributable to members was $7,341,585.
- Breathe Life Sciences, a subsidiary, is a market leader in medicinal cannabis, MDMA, and Psilocybin manufacturing.
- The company expanded its manufacturing operations in Australia during the half year.
- Bioxyne maintains a strategic focus on pharmaceutical manufacturing and distribution.
- The company completed a dual listing on the Frankfurt Stock Exchange.
- Bioxyne has secured a non-dilutive funding to establish a GMP manufacturing facility in Scotland.
- The company achieved a significant milestone with the commercial release of GMP-certified MDMA capsules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,393 |
Notification of cessation of securities - EQR
|
26 Feb 2026 9:45AM |
$0.235 |
$0.275 |
risen by
17.02%
|
|
| Bendigo and Adelaide Bank Limited (BEN) ORDINARY FULLY PAID |
Financials |
$6,128 |
Notification regarding unquoted securities - BEN
|
26 Feb 2026 9:45AM |
$10.810 |
$10.570 |
fallen by
2.22%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,508 |
Appendix 4G
|
26 Feb 2026 9:45AM |
$1.635 |
$2.120 |
risen by
29.66%
|
|
| Objective Corporation Limited (OCL) ORDINARY FULLY PAID |
Information Technology |
$1,119 |
First Half FY2026 Investor Presentation
|
26 Feb 2026 9:45AM |
$13.870 |
$11.660 |
fallen by
15.93%
|
|
OCL - Price-sensitive ASX Announcement
Full Release
Key Points
- 24% growth in SaaS revenue.
- 12% increase in annual recurring revenue.
- Expansion of cloud solutions and AI capabilities.
- Strong R&D investment focused on AI.
- Targeting 10-14% ARR growth in FY2026.
- Expansion in Australia, New Zealand, and UK markets.
- Significant enhancements in digital government solutions.
- Commitment to innovation and customer satisfaction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,508 |
FY25 Corporate Governance Statement
|
26 Feb 2026 9:44AM |
$1.635 |
$2.120 |
risen by
29.66%
|
|
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$41 |
Investor Presentation
|
26 Feb 2026 9:44AM |
$0.033 |
$0.031 |
fallen by
6.06%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,508 |
FY25 Sustainability Report
|
26 Feb 2026 9:44AM |
$1.635 |
$2.120 |
risen by
29.66%
|
|
| Spark New Zealand Limited (SPK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$3,260 |
Application for quotation of securities - SPK
|
26 Feb 2026 9:44AM |
$1.900 |
$1.725 |
fallen by
9.21%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,508 |
FY25 Annual Report
|
26 Feb 2026 9:43AM |
$1.635 |
$2.120 |
risen by
29.66%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$73 |
Section 708A Cleansing Statement
|
26 Feb 2026 9:42AM |
$0.115 |
$0.140 |
risen by
21.74%
|
|
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$48 |
Trading Halt
|
26 Feb 2026 9:42AM |
$0.800 |
$0.740 |
fallen by
7.50%
|
|
FND - Price-sensitive ASX Announcement
Full Release
Key Points
- Findi Limited (ASX: FND) has requested a trading halt pending an announcement.
- The trading halt is in accordance with ASX Listing Rule 17.1.
- The halt is due to a proposed capital raising by the Company.
- The trading halt is expected to be resolved by an announcement before 2 March 2026.
- ASX Compliance issued the trading halt notice.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kairos Minerals Limited (KAI) ORDINARY FULLY PAID |
Materials |
- |
Consolidation/Split - KAI
|
26 Feb 2026 9:41AM |
$0.039 |
$0.710 |
risen by
1,720.51%
|
|
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$22 |
Appendix 4D and Half Year Report ended 31 Dec 2025
|
26 Feb 2026 9:41AM |
$0.038 |
$0.024 |
fallen by
36.84%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 6% to AUD 2,180,481.
- Loss after tax reduced by 36% to AUD 1,764,894.
- No dividends were declared or paid during the period.
- Net tangible assets per ordinary security were AUD 0.64.
- Capital raise completed with AUD 1,363,611 collected during the half-year.
- Cash and cash equivalents at 31 December 2025 were AUD 3.5 million.
- Significant focus on cost optimisation and commercialisation of new tests.
- Business development included OEM opportunities and expanding product offerings.
- No significant changes in state of affairs during the financial half-year.
- No subsequent events significantly affecting future operations were noted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LDR Capital Property Fund (LED) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$204 |
1H26 Results Investor Briefing and Webcast Details
|
26 Feb 2026 9:41AM |
$0.560 |
$0.500 |
fallen by
10.71%
|
|
| La Trobe Private Credit Fund (LF1) ORDINARY UNITS FULLY PAID |
Financials |
$262 |
Half Yearly Report and Accounts
|
26 Feb 2026 9:41AM |
$1.955 |
$1.915 |
fallen by
2.05%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$193 |
1H26 Investor Presentation
|
26 Feb 2026 9:40AM |
$0.250 |
$0.185 |
fallen by
26%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- BETR Entertainment Limited experienced a 25% growth in turnover in H1 FY26.
- The company faced a $13.2 million EBITDA loss in H1 FY26 due to customer-friendly results and strategic marketing investments.
- Net win margins normalized in December and January, aligning with long-term trends.
- Strategic investments were made in technology and marketing for future profitability.
- BETR anticipates profitability at scale by FY27, with EBITDA targets set for H2 FY26 and FY27.
- Marketing expenses increased due to strategic, front-weighted investments.
- The company is focused on leveraging AI and data to enhance margins and profitability.
- BETR is actively pursuing M&A opportunities to create shareholder value.
- There is an ongoing share buy-back program to optimize shareholder returns.
- The NAB loan facility was extended to July 2027 for funding flexibility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ambertech Limited (AMO) ORDINARY FULLY PAID |
Information Technology |
$10 |
Appendix 4D and Half Year Financial Report
|
26 Feb 2026 9:40AM |
$0.150 |
$0.110 |
fallen by
26.67%
|
|
AMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 7% to $48.5 million for the half-year ended 31 December 2025.
- Statutory net loss after tax was $2.6 million, significantly impacted by restructuring costs.
- Strategic business reset included a $0.96 million goodwill impairment and $1.9 million in inventory impairment.
- Focus placed on inventory optimization and cost base realignment.
- The report is based on externally reviewed financial statements.
- No interim dividend declared; a fully franked final dividend of 0.6 cents per share was paid.
- The strategic reset aims to improve capital efficiency and sustainable profitability.
- Board anticipates improved financial performance in the second half of FY26.
- Directors emphasize disciplined capital management and sustainable shareholder returns.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Finexia Financial Group Limited (FNX) ORDINARY FULLY PAID |
Financials |
$11 |
Delay in 2026 Half Year Accounts
|
26 Feb 2026 9:40AM |
$0.180 |
$0.180 |
fallen by
0%
|
|
FNX - Price-sensitive ASX Announcement
Full Release
Key Points
- New auditor appointed on 27 January 2026.
- Accounting issues are technical, affecting interpretations of standards.
- Potential suspension of securities if accounts not lodged by 27 February 2026.
- Business is structurally sound and remains a going concern.
- Continuous disclosure obligations will be met with ongoing updates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greenvale Energy Limited (GRV) ORDINARY FULLY PAID |
Energy |
$20 |
Targets Identified at Douglas River
|
26 Feb 2026 9:40AM |
$0.035 |
$0.034 |
fallen by
2.86%
|
|
GRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration Licence EL34157 granted for Douglas River Uranium Project.
- Project located in Pine Creek Orogen, a region with significant uranium deposits.
- Four priority target areas identified across exploration licences.
- Sentinel-2 data reveals radiometric, multispectral, and structural anomalies.
- Potential for uranium mineralisation similar to Thunderball deposit.
- Stakeholder engagement and permitting processes initiated.
- Fieldwork including AEM and gravity surveys planned for 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
